What is JNJ's current stock price?

As of now, JNJ is trading at $205.33, with a daily change of -0.04%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ

Johnson & Johnson

$205.33

-$0.09 | -0.04%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$207.81

MKT CAP

$494.70B

52W Low

$140.68

VOL

$7.48M

P/E Ratio

19.82

AVG VOL

$8.73M

RSI

72.91

TREND

Uptrend

JNJ Stock IQ

Login to see Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

JNJ Target Price

Login to display

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Upgraded on attractively valued

JNJ Rewards

Investors confidence is positive

JNJ Rewards

Pays a reliable dividend

JNJ Price Performance

$186 (+10.39%)

$176.96 (+16.03%)

$156.81 (+30.94%)

$143.85 (+42.74%)

1year

6month

3month

1month

JNJ Risk Level

JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

JNJ Analysts Opinion

JNJ overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is negative and has getting worse from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

29%

71%

JNJ Street Sentiment

JNJ Street Sentiment is bullish and have positive views on the near-term outlook

JNJ Performance Sentiment

Sentiments overview associated with JNJ events and the stock performance.

74%

13%

Positive

Negative

34 out of 46
events present

6 out of 46
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$207.56

Resistance
Price

$186.00

Current Price Range

$207.56

Show methods +

Linked to JNJ

IQ

Close Price

Change

NBTX

4.00

21.03

+2.64%

BLTE

3.66

151.79

+0.63%

ANNX

3.83

4.28

+5.42%

REGN

4.20

723.67

-2.47%

PFE

3.94

25.57

+1.67%

JNJ Latest Analysis +

Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Today

$205.33 | -0.04%

Activity

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?. Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Today

$205.33 | -0.04%

Activity

Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates. Johnson &. Johnson (NYSE:JNJ) is included among the 15 Dividend Stocks that Outperform the S&.P 500. Barclays lifted its price⁠ tar⁠g⁠et o⁠n Johnson &. Johnson (NYSE:JNJ) to $197 from $176 on December 2 while maintaining an E‌qua‌l Weight rating. Th‍e fi‍rm also refreshe⁠d its‌ estimates for the compan⁠y. Johnson &. Johnson (NYSE:JNJ) continues t⁠o⁠ b‌enefit [….]

Today

$205.33 | -0.04%

Potential

Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation. Fintel reports that on December 2 2025 Barclays maintained coverage of Johnson &. Johnson (NYSE:JNJ) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 0.09% Downside

Today

$205.33 | -0.04%

Potential

Rating

Johnson & Johnsons (JNJ) Multiple Myeloma Breakthrough Drives Buy Rating From Guggenheim. Johnson &. Johnson (NYSE:JNJ) ranks among the Best Low Volatility Investments in December 2025. On November 25 Guggenheim reaffirmed a Buy rating and $206 price target on healthcare giant Johnson &. Johnson (NYSE:JNJ) citing favorable clinical trial findings for its multiple myeloma therapy. The firm noted preliminary data from the MajesTEC-3 trial which combines Johnson [….]

Today

$205.33 | -0.04%

Rating

JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis. J&J gains EU approval for Imaavy the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.

Tue Dec 2, 2025

$205.42 | -0.01%

Activity

Snatch This Bargain Even Cheaper Than Director Morikis Did. Theres an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock but only one reason to buy. Back on November 26 Johnson &. Johnsons Director John G. Morikis invested $257687.50 into 1250 shares of JNJ for a cost per share of

Tue Dec 2, 2025

$205.42 | -0.01%

Momentum

Potential

Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight. Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies |. DelveInsightThe dynamics of the geographic atrophy market are expected to change in the coming years due to the rising global prevalence driven by aging populations demand for disease-mod

Mon Dec 1, 2025

$205.34 | -0.78%

Activity

JNJs Oncology Momentum Builds as It Chases $50B Goal by 2030 . JNJs oncology sales surge on strong drug launches and pipeline momentum raising the stakes for its ambitious $50B 2030 goal.

Fri Nov 28, 2025

$206.92 | -0.31%

Activity

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wed Nov 26, 2025

$207.56 | +0.43%

Potential

FAQ About JNJ Stock Insights

What is JNJ current stock price?

What are JNJ stock strengths?

What is JNJ Risk Level?

What is JNJ market cap and volume?

What is JNJ current Stock IQ?

Should I buy JNJ stock right now?

Is JNJ a Strong Buy right now?

What does a 'Strong Buy' rating mean for JNJ?

What does a 'Strong Sell' rating mean for JNJ?

What factors influence JNJ's Stock IQ?

Explore our JNJ Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored JNJ Stock Strategies
Effective Risk Management

FIND US ON

Receive our JNJ Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

JNJ

Johnson & Johnson

Current Price

$205.33

-$0.09 | -0.04%

52W High

$207.81

MKT CAP

$494.70B

52W Low

$140.68

VOL

$7.48M

P/E Ratio

19.82

AVG VOL

$8.73M

RSI

72.91

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

JNJ Rewards

Earnings are forecast to grow

JNJ Rewards

Upgraded on attractively valued

JNJ Rewards

Investors confidence is positive

JNJ Rewards

Pays a reliable dividend

Linked to JNJ

Symbol

IQ

Close

Change

NBTX

4.00

21.03

+2.64%

BLTE

3.66

151.79

+0.63%

ANNX

3.83

4.28

+5.42%

REGN

4.20

723.67

-2.47%

PFE

3.94

25.57

+1.67%

JNJ Price Performance

$186 (+10.39%)

$176.96 (+16.03%)

$156.81 (+30.94%)

$143.85 (+42.74%)

1year

6month

3month

1month

JNJ Analysts Opinion

JNJ Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

JNJ Analysts Opinion

JNJ Analysts opinion is negative and has getting worse from the past 3 months

JNJ Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

29%

71%

JNJ Street Sentiment

JNJ Street Sentiment is bullish and have positive views on the near-term outlook

JNJ Risk Level

JNJ has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

JNJ Performance Sentiment

Sentiments overview associated with JNJ events and the stock performance.

74%

13%

Positive

Negative

34 out of 46
events present

6 out of 46
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$207.56

Resistance
Price

$186.00

Current Price Range

$207.56

Show methods +

JNJ Stock IQ

Login to unlock Johnson & Johnson (JNJ) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

JNJ Latest Analysis

Johnson & Johnson (JNJ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Today

$205.33 | -0.04%

Activity

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?. Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore it is wise to be aware of the facts that can impact the stocks prospects.

Today

$205.33 | -0.04%

Activity

Barclays Raises Johnson & Johnson (JNJ) Price Target After Updated Estimates. Johnson &. Johnson (NYSE:JNJ) is included among the 15 Dividend Stocks that Outperform the S&.P 500. Barclays lifted its price⁠ tar⁠g⁠et o⁠n Johnson &. Johnson (NYSE:JNJ) to $197 from $176 on December 2 while maintaining an E‌qua‌l Weight rating. Th‍e fi‍rm also refreshe⁠d its‌ estimates for the compan⁠y. Johnson &. Johnson (NYSE:JNJ) continues t⁠o⁠ b‌enefit [….]

Today

$205.33 | -0.04%

Potential

Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation. Fintel reports that on December 2 2025 Barclays maintained coverage of Johnson &. Johnson (NYSE:JNJ) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 0.09% Downside

Today

$205.33 | -0.04%

Potential

Rating

Johnson & Johnsons (JNJ) Multiple Myeloma Breakthrough Drives Buy Rating From Guggenheim. Johnson &. Johnson (NYSE:JNJ) ranks among the Best Low Volatility Investments in December 2025. On November 25 Guggenheim reaffirmed a Buy rating and $206 price target on healthcare giant Johnson &. Johnson (NYSE:JNJ) citing favorable clinical trial findings for its multiple myeloma therapy. The firm noted preliminary data from the MajesTEC-3 trial which combines Johnson [….]

Today

$205.33 | -0.04%

Rating

JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis. J&J gains EU approval for Imaavy the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.

Tue Dec 2, 2025

$205.42 | -0.01%

Activity

Snatch This Bargain Even Cheaper Than Director Morikis Did. Theres an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock but only one reason to buy. Back on November 26 Johnson &. Johnsons Director John G. Morikis invested $257687.50 into 1250 shares of JNJ for a cost per share of

Tue Dec 2, 2025

$205.42 | -0.01%

Momentum

Potential

Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight. Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies |. DelveInsightThe dynamics of the geographic atrophy market are expected to change in the coming years due to the rising global prevalence driven by aging populations demand for disease-mod

Mon Dec 1, 2025

$205.34 | -0.78%

Activity

JNJs Oncology Momentum Builds as It Chases $50B Goal by 2030 . JNJs oncology sales surge on strong drug launches and pipeline momentum raising the stakes for its ambitious $50B 2030 goal.

Fri Nov 28, 2025

$206.92 | -0.31%

Activity

Johnson & Johnson (JNJ) is a Top-Ranked Momentum Stock: Should You Buy?. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wed Nov 26, 2025

$207.56 | +0.43%

Potential

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of JNJ. We're here to help you make informed investment decisions today.

FIND US ON

Receive our JNJ Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

JNJ Stock trends

JNJ Stock performance

JNJ Stock analysis

JNJ investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing JNJ

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

JNJ Stock Analysis & IQ Rating | Johnson & Johnson

JNJ Stock IQ

JNJ Target Price

JNJ Risk Level

JNJ Analysts Opinion

JNJ Street Sentiment

JNJ Performance Sentiment

Technical Price Levels

Explore our JNJ Stock insights

Receive our JNJ Daily Alerts

JNJ Street Sentiment

JNJ Risk Level

Technical Price Levels

Discover JNJ Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of JNJ. We're here to help you make informed investment decisions today.

Receive our JNJ Daily Alerts

JNJ Runner Alarm